{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:04:56Z","timestamp":1780049096515,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/bf03018576","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T19:58:39Z","timestamp":1241380719000},"page":"26-29","source":"Crossref","is-referenced-by-count":74,"title":["FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: A report of four cases","Le FVIIa corrige la coagulopathie d\u2019une insuffisance h\u00e9patique fulminante, mais peut \u00eatre associ\u00e9 \u00e0 la thrombose: pr\u00e9sentation de quatre cas"],"prefix":"10.1007","volume":"52","author":[{"given":"Patricia","family":"Pavese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Bonadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Beaubien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Labrecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Pernod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Letoublon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Barnoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"BF03018576_CR1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/00001721-200004001-00017","volume":"11","author":"HG Hendricks","year":"2000","unstructured":"Hendricks HG, van der Meer J, Klompmaker IJ, et al. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S87\u201393.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018576_CR2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1213\/01.ANE.0000073354.38695.7C","volume":"97","author":"Y Ozier","year":"2003","unstructured":"Ozier Y, Pessione F, Samain E, Courtois F, French study group on blood transfusion in liver transplantation. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97: 671\u20139.","journal-title":"Anesth Analg"},{"key":"BF03018576_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-200102150-00011","volume":"71","author":"HG Hendricks","year":"2001","unstructured":"Hendricks HG, Meijer K, De Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation. Transplantation 2001; 71: 402\u20135.","journal-title":"Transplantation"},{"key":"BF03018576_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/jlts.2003.50017","volume":"9","author":"VM Shami","year":"2003","unstructured":"Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003; 9: 138\u201343.","journal-title":"Liver Transpl"},{"issue":"1","key":"BF03018576_CR5","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00001721-200004001-00020","volume":"11","author":"U Hedner","year":"2000","unstructured":"Hedner U. NovoSeven\u00ae as a universal haemostatic agent. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S107\u201311.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"BF03018576_CR6","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00001721-200004001-00013","volume":"11","author":"MC Poon","year":"2000","unstructured":"Poon MC, d\u2019Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S55\u201368.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"BF03018576_CR7","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00001721-200004001-00021","volume":"11","author":"E Berntorp","year":"2000","unstructured":"Berntorp E, Stigendal L, Lethagen S, Olofsson L, Hedner U. NovoSeven\u00ae in warfarin-treated patients. Blood Coagul Fibrinolysis 2000; 11(Suppl 1): S113\u20135.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018576_CR8","first-page":"431","volume":"51","author":"U Martinowitz","year":"2001","unstructured":"Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431\u20139.","journal-title":"J Trauma"},{"key":"BF03018576_CR9","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1007\/s00134-002-1470-8","volume":"28","author":"SA Mayer","year":"2002","unstructured":"Mayer SA. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy. Intensive Care Med 2002; 28: S235\u201340.","journal-title":"Intensive Care Med"},{"key":"BF03018576_CR10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0016-5085(97)70013-1","volume":"113","author":"DE Bernstein","year":"1997","unstructured":"Bernstein DE, Jeffers L, Erhardtsen E, et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997; 113: 1930\u20137.","journal-title":"Gastroenterology"},{"key":"BF03018576_CR11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(01)01116-0","volume":"112","author":"PW Kamphuisen","year":"2002","unstructured":"Kamphuisen PW, van den Akker JM, Kaasjager KA, Bloemen TL. Control of life-threatening pulmonary bleeding with activated recombinant factor VII (Letter). Am J Med 2002; 112: 332\u20133.","journal-title":"Am J Med"},{"key":"BF03018576_CR12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.1999.01798.x","volume":"107","author":"B White","year":"1999","unstructured":"White B, McHale J, Ravi N, et al. Successful use of recombinant FVIIa (Novoseven) in the management of intractable post-surgical intra-abdominal haemorrhage (Letter). Br J Haematol 1999; 107: 677\u20138.","journal-title":"Br J Haematol"},{"key":"BF03018576_CR13","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/00000542-200206000-00039","volume":"96","author":"JD Tobias","year":"2002","unstructured":"Tobias JD. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002; 96: 1522\u20135.","journal-title":"Anesthesiology"},{"key":"BF03018576_CR14","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-200206000-00041","volume":"96","author":"E Svartholm","year":"2002","unstructured":"Svartholm E, Annerhagen V, Lanne T. Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa (Letter). Anesthesiology 2002; 96: 1528.","journal-title":"Anesthesiology"},{"key":"BF03018576_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","volume":"361","author":"PW Friederich","year":"2003","unstructured":"Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003; 361: 201\u20135.","journal-title":"Lancet"},{"key":"BF03018576_CR16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","volume":"80","author":"AD Shapiro","year":"1998","unstructured":"Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773\u20138.","journal-title":"Thromb Haemost"},{"key":"BF03018576_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2516.2002.00667.x","volume":"8","author":"EP Mauser-Brunschoten","year":"2002","unstructured":"Mauser-Brunschoten EP, Koopman MM, de Goede-Bolder AD, et al. Efficacy of recombinant factor VII administered by continuous infusion to haemophilia patients with inhibitors. Haemophilia 2002; 8: 649\u201356.","journal-title":"Haemophilia"},{"key":"BF03018576_CR18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00000542-200206000-00004","volume":"96","author":"RB Weiskopf","year":"2002","unstructured":"Weiskopf RB. Intraoperative use of recombinant activated coagulation factor VII (Editorial). Anesthesiology 2002; 96: 1287\u20139.","journal-title":"Anesthesiology"},{"key":"BF03018576_CR19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2165\/00003495-200262150-00003","volume":"62","author":"RJ Porte","year":"2002","unstructured":"Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 2002; 62: 2193\u2013211.","journal-title":"Drugs"},{"key":"BF03018576_CR20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00001721-200312000-00004","volume":"14","author":"JW Eikelboom","year":"2003","unstructured":"Eikelboom JW, Bird R, Blythe D, et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 2003; 14: 713\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03018576_CR21","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/S0041-1345(03)00784-X","volume":"35","author":"M Markiewicz","year":"2003","unstructured":"Markiewicz M, Kalicinski P, Kaminski A, et al. Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII. Transplant Proc 2003; 35: 2318\u20139.","journal-title":"Transplant Proc"},{"key":"BF03018576_CR22","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0041-1345(03)00759-0","volume":"35","author":"T Surudo","year":"2003","unstructured":"Surudo T, Wojcicki M, Milkiewicz P, et al. Rapid correction of prothrombin time after low-dose recombinant factor VIIa in patients undergoing orthotopic liver transplantation. Transplant Proc 2003; 35: 2323\u20135.","journal-title":"Transplant Proc"},{"key":"BF03018576_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00000542-200402000-00037","volume":"100","author":"LJ Siegel","year":"2004","unstructured":"Siegel LJ, Gerigk L, Tuettenberg J, Dempfle CE, Scharf J, Fiedler F. Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion. Anesthesiolgy 2004; 100: 441\u20133.","journal-title":"Anesthesiolgy"},{"key":"BF03018576_CR24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1046\/j.0041-1132.2003.00577.x","volume":"43","author":"NM O\u2019Connell","year":"2003","unstructured":"O\u2019Connell NM, Perry DJ, Hodgson AJ, O\u2019Shaughnessy DF, Laffan MA, Smith OP. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003; 43: 1711\u20136.","journal-title":"Transfusion"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03018576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03018576\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03018576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:59:15Z","timestamp":1558479555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03018576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["BF03018576"],"URL":"https:\/\/doi.org\/10.1007\/bf03018576","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}